| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3903842 | Urology | 2009 | 14 Pages |
Abstract
There was a lack of RCTs reporting long-term (>6 months) harms data. In short-term trials, men with ED randomized to sildenafil had an increased risk of all-cause any AEs, headache, flushing, dyspepsia, and visual disturbances. The exploration of different modes of dose optimization of sildenafil may be warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Alexander Tsertsvadze, Fatemeh Yazdi, Howard A. Fink, Roderick MacDonald, Timothy J. Wilt, Anthony J. Bella, Mohammed T. Ansari, Chantelle Garritty, Karla Soares-Weiser, Raymond Daniel, Margaret Sampson, David Moher,